Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladine

Breast Cancer Research and Treatment

Volumn 83, Issue 3, 2004, Pages 195-199

  Nozaki, Shinichi ^a   Maeda, Mitsuaki ^b   Tsuda, Hiroyuki ^b   Sledge Jr , George W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Angiogenesis; Anti tumor activity; Matrix metalloproteinase 1; Orthotopic transplant model; Urokinase plasminogen activator

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIULCER AGENT; IRSOGLADINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; BREAST CARCINOMA; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS; TRIAZINES;

EID: 1342326916     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000013996.49528.d8     Document Type: Article

References (24)

1. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991
2. Fidler LJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 85-88, 1994
3. Barinaga M: Designing therapies that target tumor blood vessels. Science 275: 482-484, 1997
4. Twardowski P, Gradishar WJ: Clinical trial of antiangiogenic agents. Curr Opin Oncol 9: 584-589, 1997
5. Tsuruoka N, Sugiyama M, Tawaragi Y, Tsujimoto M, Nishihara T, Goto T, Sato N: Inhibition of in vitro angiogenesis by lymphotaxin and interferon-gamma. Biochem Biophys Res Commun 155: 429-435, 1988
6. Tamargo RJ, Bok RA, Brem H: Angiogenesis inhibition by minocycline. Cancer Res 51: 672-675, 1991
7. Gagliardi A, Collins DC: Inhibition of angiogenesis by anti-estrogens. Cancer Res 53: 533-535, 1993
8. D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085, 1994
9. Ueda F, Kyoi T, Mimura K, Kimura K, Yamamoto M: Intercellular communication in cultured rabbit gastric epithelial cells. Jpn J Pharmacol 57: 321-328, 1991
10. Sato Y, Morimoto A, Kiue A, Okamura K, Hamanaka R, Kohno K, Kuwano M, Sakata, T: Irsogladine is a potent inhibitor of angiogenesis. FEBS Lett 322: 155-158, 1993
11. Ono M, Kawahara N, Goto D, Wakabayashi Y, Ushiro S, Yoshida S, Izumi H, Kuwano M, Sato Y: Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine. Cancer Res 56: 1512-1516, 1996
12. Sledge Jr GW, Qulali M, Goulet R, Bone EA, Fife R: Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 87: 1546-1550, 1995
13. Nozaki S, Sledge Jr GW, Nakshatri H: Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun 275: 60-62, 2000
14. Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet Jr RJ, Sledge Jr GW, Nakshatri H: Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene 19: 4159-4169, 2000
15. Hosokawa T, Otani Y, Ogawa K, Kajiwara T: Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. J Cancer Res Clin Oncol 118: 565-566, 1992
16. Hosokawa T, Ogawa K, Otani Y, Kajiwara T: Two cases of gastric cancer remarkably reduced with a combined dosage of irsogladine maleate preparation and UFT. Oncol Rep 1: 93-95, 1994
17. Sugie S, Okamoto K, Ueda F, Watanabe T, Tanaka T, Mori H: Suppressive effect of irsogladine maleate on diethylnitrosamine-initiated and phenobarbital-prompted hepatocarcinogenesis in male F344 rats. Jpn J Cancer Res 89: 371-376, 1998
18. Hirose Y, Tanaka T, Makita H, Yang M, Satoh K, Hara A, Maeda M, Toriyama HB, Mori H, Tsuda H: Suppressing effects of 6-(2,5-dichlorophenyl)-2,4-diamino- 1,3,5-triazine and related synthetic compounds on azoxymethane-induced aberrant crypt foci in rat colon. Jpn J Cancer Res 87: 549-554, 1996
19. Janicke F, Schmitt M, Graeff H: Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. Semin Thromb Hemostas 17: 303-312, 1991
20. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296: 803-809, 1993
21. Fisher C: Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA: Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162: 499-510, 1994
22. Okamura K, Sato Y, Matsuda T, Hamanaka R, Ono M, Kohno K, Kuwano M: Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. J Biol Chem 266: 19162-19165, 1991
23. Ren CJ, Ueda F, Roses DF, Harris MN, Mignatti P, Rifkin DB, Shapiro RL: Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice. J Surg Res 77: 126-131, 1998
24. Pepper MS, Spray DC, Chanson M, Montesano R, Orci L, Meda P: Junctional communication is induced in migrating capillary endothelial cells. J Cell Biol 109: 3027-3038, 1989